✦ LIBER ✦
NPM-ALK modulates the p53 tumour suppressor pathway in a JNK and PI 3-Kinase dependent manner: MDM-2 is a potential therapeutic target for the treatment of ALK-expressing malignancies
✍ Scribed by Y. Cui; A. Kerby; F.K.E. McDuff; S.D. Turner
- Book ID
- 119598544
- Publisher
- Elsevier Science
- Year
- 2008
- Tongue
- English
- Weight
- 90 KB
- Volume
- 6
- Category
- Article
- ISSN
- 1359-6349
No coin nor oath required. For personal study only.